Fig. 5 | British Journal of Cancer

Fig. 5

From: Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma

Fig. 5

B cell lymphoma growth in mice treated with checkpoint inhibitors and/or different types of chemotherapy drugs. To generate syngeneic models of B-cell lymphoma in BALB/c mice, 5 × 106 A20 B cell lymphoma cells were injected subcutaneously into the right flank. Tumour growth was monitored weekly. Mice were treated with checkpoint inhibitors anti-PD-1 or anti-PD-L1 and/or different dosages of V or C. (n = 5 per study arm; *p < 0.05, **p < 0.01, ***p < 0.001)

Back to article page